Common Stock, Shares, Outstanding of ARROWHEAD PHARMACEUTICALS, INC. from 30 Sep 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
ARROWHEAD PHARMACEUTICALS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2010 to 31 Dec 2025.
  • ARROWHEAD PHARMACEUTICALS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 137,391,000, a 9.4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ARROWHEAD PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 137,391,000 +11,819,000 +9.4% 31 Dec 2025 10-Q 05 Feb 2026 2026 Q1
Q3 2025 135,702,000 +11,326,000 +9.1% 30 Sep 2025 10-Q 05 Feb 2026 2026 Q1
Q2 2025 138,144,000 +13,917,000 +11% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q3
Q1 2025 138,062,000 +13,929,000 +11% 31 Mar 2025 10-Q 12 May 2025 2025 Q2
Q4 2024 125,572,000 +18,072,000 +17% 31 Dec 2024 10-Q 10 Feb 2025 2025 Q1
Q3 2024 124,376,000 +17,064,000 +16% 30 Sep 2024 10-K 25 Nov 2025 2025 FY
Q2 2024 124,227,000 +17,125,000 +16% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q3
Q1 2024 124,133,000 +17,264,000 +16% 31 Mar 2024 10-Q 09 May 2024 2024 Q2
Q4 2023 107,500,000 +1,360,000 +1.3% 31 Dec 2023 10-Q 06 Feb 2024 2024 Q1
Q3 2023 107,312,000 +1,352,000 +1.3% 30 Sep 2023 10-K 26 Nov 2024 2024 FY
Q2 2023 107,102,000 +1,306,544 +1.2% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q3
Q1 2023 106,869,000 +1,166,501 +1.1% 31 Mar 2023 10-Q 02 May 2023 2023 Q2
Q4 2022 106,140,000 +1,341,814 +1.3% 31 Dec 2022 10-Q 06 Feb 2023 2023 Q1
Q3 2022 105,960,000 +1,633,000 +1.6% 30 Sep 2022 10-K 29 Nov 2023 2023 FY
Q2 2022 105,795,456 +1,586,109 +1.5% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q3
Q1 2022 105,702,499 +1,682,953 +1.6% 31 Mar 2022 10-Q 10 May 2022 2022 Q2
Q4 2021 104,798,186 +1,603,946 +1.6% 31 Dec 2021 10-Q 02 Feb 2022 2022 Q1
Q3 2021 104,327,000 +1,951,000 +1.9% 30 Sep 2021 10-K 28 Nov 2022 2022 FY
Q2 2021 104,209,347 +1,958,475 +1.9% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q3
Q1 2021 104,019,546 +2,271,439 +2.2% 31 Mar 2021 10-Q 04 May 2021 2021 Q2
Q4 2020 103,194,240 +2,082,443 +2.1% 31 Dec 2020 10-Q 04 Feb 2021 2021 Q1
Q3 2020 102,376,000 +6,869,729 +7.2% 30 Sep 2020 10-K 22 Nov 2021 2021 FY
Q2 2020 102,250,872 +7,043,235 +7.4% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q3
Q1 2020 101,748,107 +7,082,389 +7.5% 31 Mar 2020 10-Q 07 May 2020 2020 Q2
Q4 2019 101,111,797 +8,520,340 +9.2% 31 Dec 2019 10-Q 05 Feb 2020 2020 Q1
Q3 2019 95,506,271 +7,000,969 +7.9% 30 Sep 2019 10-K 23 Nov 2020 2020 FY
Q2 2019 95,207,637 +7,352,986 +8.4% 30 Jun 2019 10-Q 05 Aug 2019 2019 Q3
Q1 2019 94,665,718 +7,095,320 +8.1% 31 Mar 2019 10-Q 08 May 2019 2019 Q2
Q4 2018 92,591,457 +17,673,581 +24% 31 Dec 2018 10-Q 07 Feb 2019 2019 Q1
Q3 2018 88,505,302 +13,719,576 +18% 30 Sep 2018 10-K 25 Nov 2019 2019 FY
Q2 2018 87,854,651 +13,082,548 +17% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q3
Q1 2018 87,570,398 +12,798,295 +17% 31 Mar 2018 10-Q 08 May 2018 2018 Q2
Q4 2017 74,917,876 +504,836 +0.68% 31 Dec 2017 10-Q 09 Feb 2018 2018 Q1
Q3 2017 74,785,726 +5,039,041 +7.2% 30 Sep 2017 10-K 11 Dec 2018 2018 FY
Q2 2017 74,772,103 +14,342,698 +24% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q3
Q1 2017 74,772,103 +14,811,392 +25% 31 Mar 2017 10-Q 03 May 2017 2017 Q2
Q4 2016 74,413,040 +14,785,541 +25% 31 Dec 2016 10-Q 06 Feb 2017 2017 Q1
Q3 2016 69,746,685 +10,202,008 +17% 30 Sep 2016 10-K 12 Dec 2017 2017 FY
Q2 2016 60,429,405 +931,043 +1.6% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q3
Q1 2016 59,960,711 +524,849 +0.88% 31 Mar 2016 10-Q 10 May 2016 2016 Q2
Q4 2015 59,627,499 +4,911,785 +9% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q1
Q3 2015 59,544,677 +4,887,741 +8.9% 30 Sep 2015 10-K 14 Dec 2016 2016 FY
Q2 2015 59,498,362 +6,589,795 +12% 30 Jun 2015 10-Q 04 Aug 2015 2015 Q3
Q1 2015 59,435,862 +7,568,791 +15% 31 Mar 2015 10-Q 11 May 2015 2015 Q2
Q4 2014 54,715,714 +15,713,562 +40% 31 Dec 2014 10-Q 09 Feb 2015 2015 Q1
Q3 2014 54,656,936 +22,167,492 +68% 30 Sep 2014 10-K 14 Dec 2015 2015 FY
Q2 2014 52,908,567 +21,602,249 +69% 30 Jun 2014 10-Q 12 Aug 2014 2014 Q3
Q1 2014 51,867,071 +34,824,307 +204% 31 Mar 2014 10-Q 06 May 2014 2014 Q2
Q4 2013 39,002,152 +23,357,994 +149% 31 Dec 2013 10-Q 04 Feb 2014 2014 Q1
Q3 2013 32,489,444 +18,910,259 +139% 30 Sep 2013 10-K 25 Nov 2014 2014 FY
Q2 2013 31,306,318 +19,995,502 +177% 30 Jun 2013 10-Q 07 Aug 2013 2013 Q3
Q1 2013 17,042,764 +6,236,458 +58% 31 Mar 2013 10-Q 09 May 2013 2013 Q2
Q4 2012 15,644,158 +5,113,634 +49% 31 Dec 2012 10-Q 13 Feb 2013 2013 Q1
Q3 2012 13,579,185 +4,936,899 +57% 30 Sep 2012 10-K 18 Dec 2013 2013 FY
Q2 2012 11,310,816 -60,522,877 -84% 30 Jun 2012 10-Q 13 Aug 2012 2012 Q3
Q1 2012 10,806,306 31 Mar 2012 10-Q 08 May 2012 2012 Q2
Q4 2011 10,530,524 31 Dec 2011 10-Q 09 Feb 2012 2012 Q1
Q3 2011 8,642,286 +1,470,272 +20% 30 Sep 2011 10-K 28 Dec 2012 2012 FY
Q2 2011 71,833,693 30 Jun 2011 10-Q 08 Aug 2011 2011 Q3
Q3 2010 7,172,014 30 Sep 2010 10-K 20 Dec 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.